仿制药参比制剂目录征求意见稿（最近公告）
最近公告
| 药品通用名称 | 英文名称/商品名 | 公示类型 | 参比制剂编号 | 公布批次 | 持证商 | 规格 | 剂型 | 公告时间 |
|---|---|---|---|---|---|---|---|---|
| 盐酸氨溴索喷雾剂 | Ambroxol Hydrochloride Spray | 增补品种 | 110-11 | 110 | GMep Medical Technology GmbH | 13ml︰650mg，每喷含盐酸氨溴索 10mg，每瓶65喷 | — | 2026-09-07 |
| 芦比前列酮软胶囊 | Lubiprostone Soft Capsules/ AMITIZA | 增补品种 | 110-12 | 110 | ヴィアトリス製薬合同会社 | 24μg | — | 2026-09-07 |
| 右美沙芬安非他酮缓释片 | Dextromethorphan Hydrobromide and Bupropion Hydrochloride Extended-Release Tablets /Auvelity | 增补品种 | 110-13 | 110 | Axsome Therapeutics, Inc. | 30mg(以C18H25NO·HBr·H2O 计）/105mg(以C13H18ClNO·HCl计） | — | 2026-09-07 |
| 酒石酸伐尼克兰片 | Varenicline Tartrate Tablets/CHANTIX | 增补品种 | 110-14 | 110 | PF PRISM CV | 0.5mg | — | 2026-09-07 |
| 酒石酸伐尼克兰片 | Varenicline Tartrate Tablets/CHANTIX | 增补品种 | 110-15 | 110 | PF PRISM CV | 1.0mg | — | 2026-09-07 |
| 注射用亚胺西瑞 | Imipenem, Cilastatin and Relebactam for Injection/RECARBRIO | 增补品种 | 110-16 | 110 | MERCK SHARP AND DOHME CORP A SUB OF MERCK AND CO INC | 1.25g（C12H17N3O4S 0.5g，C16H26N2O5S 0.5g 与C12H20N4O6S 0.25g） | — | 2026-09-07 |
| 注射用盐酸依拉环素 | Eravacycline Hydrochloride for Injection /XERAVA | 增补品种 | 110-17 | 110 | TETRAPHASE PHARMACEUTICALS INC | 100mg（按C27H31FN4O8计） | — | 2026-09-07 |
| 醋酸甲地孕酮口服混悬液 | Megestrol Acetate Oral Suspension | 增补品种 | 110-18 | 110 | PHARMACEUTICAL TWIS INC | 125mg/ml（包装规格 150ml） | — | 2026-09-07 |
| 盐酸度洛西汀肠溶胶囊 | Duloxetine Hydrochloride Enteric Capsules | 增补品种 | 110-19 | 110 | Ajanta pharma Ltd | 60mg | — | 2026-09-07 |
| 盐酸度洛西汀肠溶胶囊 | Duloxetine Hydrochloride Enteric Capsules | 增补品种 | 110-20 | 110 | Ajanta pharma Ltd | 30mg | — | 2026-09-07 |